Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell of artery | 9 studies | 25% ± 6% | |
brush cell | 4 studies | 73% ± 16% | |
endocardial cell | 3 studies | 34% ± 7% | |
endothelial cell of lymphatic vessel | 3 studies | 17% ± 0% |
Insufficient scRNA-seq data for expression of BMX at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 95% | 274.66 | 620 / 653 | 63% | 2.60 | 382 / 605 |
breast | 100% | 643.25 | 457 / 459 | 50% | 1.41 | 559 / 1118 |
intestine | 97% | 375.59 | 939 / 966 | 49% | 1.94 | 259 / 527 |
lung | 98% | 387.87 | 564 / 578 | 38% | 1.73 | 444 / 1155 |
bladder | 90% | 253.71 | 19 / 21 | 35% | 2.42 | 176 / 504 |
stomach | 72% | 131.19 | 258 / 359 | 50% | 1.30 | 142 / 286 |
uterus | 95% | 311.10 | 162 / 170 | 21% | 0.83 | 96 / 459 |
esophagus | 82% | 204.78 | 1188 / 1445 | 33% | 0.77 | 61 / 183 |
adipose | 100% | 788.24 | 1200 / 1204 | 0% | 0 | 0 / 0 |
prostate | 51% | 99.62 | 124 / 245 | 49% | 2.01 | 246 / 502 |
pancreas | 11% | 14.67 | 37 / 328 | 87% | 5.12 | 154 / 178 |
blood vessel | 96% | 489.77 | 1280 / 1335 | 0% | 0 | 0 / 0 |
skin | 55% | 120.87 | 1000 / 1809 | 38% | 11.73 | 180 / 472 |
spleen | 93% | 277.26 | 223 / 241 | 0% | 0 | 0 / 0 |
heart | 87% | 487.56 | 745 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 80% | 1367.58 | 747 / 929 | 0% | 0 | 0 / 0 |
kidney | 8% | 10.55 | 7 / 89 | 67% | 2.43 | 607 / 901 |
adrenal gland | 15% | 17.14 | 39 / 258 | 33% | 0.73 | 76 / 230 |
muscle | 48% | 75.51 | 382 / 803 | 0% | 0 | 0 / 0 |
ovary | 36% | 89.77 | 65 / 180 | 5% | 0.11 | 20 / 430 |
liver | 8% | 12.18 | 19 / 226 | 15% | 0.30 | 60 / 406 |
tonsil | 0% | 0 | 0 / 0 | 13% | 0.19 | 6 / 45 |
brain | 2% | 3.85 | 63 / 2642 | 5% | 0.17 | 34 / 705 |
lymph node | 0% | 0 | 0 / 0 | 7% | 0.16 | 2 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007498 | Biological process | mesoderm development |
GO_0007165 | Biological process | signal transduction |
GO_0050853 | Biological process | B cell receptor signaling pathway |
GO_0007155 | Biological process | cell adhesion |
GO_0002250 | Biological process | adaptive immune response |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0006915 | Biological process | apoptotic process |
GO_0006468 | Biological process | protein phosphorylation |
GO_0046777 | Biological process | protein autophosphorylation |
GO_0006661 | Biological process | phosphatidylinositol biosynthetic process |
GO_0032587 | Cellular component | ruffle membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0004715 | Molecular function | non-membrane spanning protein tyrosine kinase activity |
GO_0004713 | Molecular function | protein tyrosine kinase activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0005524 | Molecular function | ATP binding |
GO_0005515 | Molecular function | protein binding |
Gene name | BMX |
Protein name | Cytoplasmic tyrosine-protein kinase BMX (EC 2.7.10.2) (Bone marrow tyrosine kinase gene in chromosome X protein) (Epithelial and endothelial tyrosine kinase) (ETK) (NTK38) |
Synonyms | |
Description | FUNCTION: Non-receptor tyrosine kinase that plays central but diverse modulatory roles in various signaling processes involved in the regulation of actin reorganization, cell migration, cell proliferation and survival, cell adhesion, and apoptosis. Participates in signal transduction stimulated by growth factor receptors, cytokine receptors, G-protein coupled receptors, antigen receptors and integrins. Induces tyrosine phosphorylation of BCAR1 in response to integrin regulation. Activation of BMX by integrins is mediated by PTK2/FAK1, a key mediator of integrin signaling events leading to the regulation of actin cytoskeleton and cell motility. Plays a critical role in TNF-induced angiogenesis, and implicated in the signaling of TEK and FLT1 receptors, 2 important receptor families essential for angiogenesis. Required for the phosphorylation and activation of STAT3, a transcription factor involved in cell differentiation. Also involved in interleukin-6 (IL6) induced differentiation. Also plays a role in programming adaptive cytoprotection against extracellular stress in different cell systems, salivary epithelial cells, brain endothelial cells, and dermal fibroblasts. May be involved in regulation of endocytosis through its interaction with an endosomal protein RUFY1. May also play a role in the growth and differentiation of hematopoietic cells; as well as in signal transduction in endocardial and arterial endothelial cells. . |
Accessions | ENST00000342014.6 ENST00000348343.11 ENST00000357607.6 P51813 |